BBNX vs CLOV · rev $65.1M vs rev $1.37B
Beta Bionics, Inc. Common Stock (BBNX) versus Clover Health Investments Corp (CLOV) — a side-by-side from cached financials, not a winner call.
Beta Bionics, Inc. Common Stock (BBNX) is a medical devices company listed on NASDAQ.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Latest reported BBNX revenue for 2024-12-31 was $65.1M. Net income was -$54.8M. Revenue was up 442.9% from 2023-12-31 to 2024-12-31. BBNX currently screens at market cap $640.8M.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
BBNX currently screens at market cap $640.8M. CLOV currently screens at market cap $1.55B.
Not investment advice. Open the BBNX and CLOV stock pages for the full models.
Not investment advice.